↓ Skip to main content

Learning From Success and Failure: Biologics for Non-approved Skin Diseases

Overview of attention for article published in Frontiers in immunology, August 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Readers on

mendeley
89 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Learning From Success and Failure: Biologics for Non-approved Skin Diseases
Published in
Frontiers in immunology, August 2019
DOI 10.3389/fimmu.2019.01918
Pubmed ID
Authors

Reinhart Speeckaert, Jo Lambert, Nanja van Geel

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 15%
Student > Doctoral Student 8 9%
Student > Bachelor 7 8%
Other 7 8%
Student > Master 7 8%
Other 8 9%
Unknown 39 44%
Readers by discipline Count As %
Medicine and Dentistry 27 30%
Pharmacology, Toxicology and Pharmaceutical Science 7 8%
Biochemistry, Genetics and Molecular Biology 6 7%
Immunology and Microbiology 5 6%
Arts and Humanities 1 1%
Other 1 1%
Unknown 42 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 August 2019.
All research outputs
#15,749,194
of 25,385,509 outputs
Outputs from Frontiers in immunology
#15,388
of 31,539 outputs
Outputs of similar age
#195,669
of 356,394 outputs
Outputs of similar age from Frontiers in immunology
#439
of 702 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,539 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,394 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 702 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.